175 related articles for article (PubMed ID: 24053578)
1. Make no bones about it: cells could soon be reprogrammed to grow replacement bones?
de Peppo GM; Marolt D
Expert Opin Biol Ther; 2014 Jan; 14(1):1-5. PubMed ID: 24053578
[TBL] [Abstract][Full Text] [Related]
2. Stem cells combined with bone graft substitutes in skeletal tissue engineering.
Gamie Z; Tran GT; Vyzas G; Korres N; Heliotis M; Mantalaris A; Tsiridis E
Expert Opin Biol Ther; 2012 Jun; 12(6):713-29. PubMed ID: 22500826
[TBL] [Abstract][Full Text] [Related]
3. Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration.
Illich DJ; Demir N; Stojković M; Scheer M; Rothamel D; Neugebauer J; Hescheler J; Zöller JE
Stem Cells; 2011 Apr; 29(4):555-63. PubMed ID: 21308867
[TBL] [Abstract][Full Text] [Related]
4. Engineering bone tissue substitutes from human induced pluripotent stem cells.
de Peppo GM; Marcos-Campos I; Kahler DJ; Alsalman D; Shang L; Vunjak-Novakovic G; Marolt D
Proc Natl Acad Sci U S A; 2013 May; 110(21):8680-5. PubMed ID: 23653480
[TBL] [Abstract][Full Text] [Related]
5. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
6. Biomaterials for Bone Regenerative Engineering.
Yu X; Tang X; Gohil SV; Laurencin CT
Adv Healthc Mater; 2015 Jun; 4(9):1268-85. PubMed ID: 25846250
[TBL] [Abstract][Full Text] [Related]
7. Macroporous scaffolds associated with cells to construct a hybrid biomaterial for bone tissue engineering.
Rosa AL; de Oliveira PT; Beloti MM
Expert Rev Med Devices; 2008 Nov; 5(6):719-28. PubMed ID: 19025348
[TBL] [Abstract][Full Text] [Related]
8. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
9. iPS cell technology in regenerative medicine.
Lengner CJ
Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
[TBL] [Abstract][Full Text] [Related]
10. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
11. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
12. Bone repair in the twenty-first century: biology, chemistry or engineering?
Hing KA
Philos Trans A Math Phys Eng Sci; 2004 Dec; 362(1825):2821-50. PubMed ID: 15539372
[TBL] [Abstract][Full Text] [Related]
13. Applied Induced Pluripotent Stem Cells in Combination With Biomaterials in Bone Tissue Engineering.
Ardeshirylajimi A
J Cell Biochem; 2017 Oct; 118(10):3034-3042. PubMed ID: 28316107
[TBL] [Abstract][Full Text] [Related]
14. [Regenerative medicine in bone tumor surgery].
Myoui A; Yoshikawa H
Clin Calcium; 2008 Dec; 18(12):1767-73. PubMed ID: 19043191
[TBL] [Abstract][Full Text] [Related]
15. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
16. Stem cell-based composite tissue constructs for regenerative medicine.
Rahaman MN; Mao JJ
Biotechnol Bioeng; 2005 Aug; 91(3):261-84. PubMed ID: 15929124
[TBL] [Abstract][Full Text] [Related]
17. [Custom-made artificial bones fabricated by an inkjet printing technology].
Igawa K; Chung UI; Tei Y
Clin Calcium; 2008 Dec; 18(12):1737-43. PubMed ID: 19043187
[TBL] [Abstract][Full Text] [Related]
18. Commercial Products for Osteochondral Tissue Repair and Regeneration.
Bicho D; Pina S; Reis RL; Oliveira JM
Adv Exp Med Biol; 2018; 1058():415-428. PubMed ID: 29691833
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cells: an emerging theranostics platform.
Nelson TJ; Terzic A
Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
[TBL] [Abstract][Full Text] [Related]
20. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
